NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

The Ethan Chen et al. article has apparently made a monumental error in that it
stated that the 23.1 months mOS of the 331 patients cited in the 2018 JTM
article was almost 4 months longer than the 19,3 months mOS of the 232 treatment
patients in the 2022 JAMA article. The authors were apparently unaware that the
mOS results in the JTM article were measured from surgery and the mOS figures
in the JAMA publication were calculated from the time of randomization.
Bottom line: the conclusions reached in this publication do not at all change my positive
opinion concerning the immense potential of DCVax-L.